Pharmaceutical giant Eli Lilly announced plans Wednesday to slash insulin prices by 70% and cap monthly costs at $35.
It comes as welcome news for some of the millions of Americans with diabetes who rely on insulin to survive.
His co-inventors, James Collip and Charles Best, sold the insulin patent to the University of Toronto for $1 to make it affordable for those who need it.Youngberg said one time she had to pay for the drug out-of-pocket, and the three-month supply cost around $500, and that's not counting the other technology she needs to track and maintain her blood sugar levels.
“The impact of having these options is literally not only someone's health and wellbeing, but you know, could potentially be saving their life," said Director of Advocacy for the Juvenile Diabetes Research Fund Aaron Turner-Phifer.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pharmaceutical Company Eli Lilly Caps Insulin Cost at $35 a MonthThe pharmaceutical company Eli Lilly is capping the out-of-pocket cost of insulin at $35 a month, a move that could help millions of Americans afford to pay for the life-saving medication. MiguelMValle explains the potential impact:
Weiterlesen »
Eli Lilly CEO says $35 for monthly insulin ‘should be the new standard in America’Eli Lilly & Co. said Wednesday it's capping out-of-pocket insulin costs at $35
Weiterlesen »
Drug Giant Eli Lilly Dramatically Slashes Price of InsulinA hard-fought campaign to reduce the exorbitant price of insulin seems to finally be yielding some results.
Weiterlesen »
Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Weiterlesen »
'Brilliant PR Move': Advocates Skeptical as Eli Lilly Vows 70% Insulin Price Cut'Congress, not greedy corporations trying to redeem their tarnished reputations, should be leading the way on reforms that put patients ahead of pharmaceutical profits.'
Weiterlesen »
Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Weiterlesen »